92 related articles for article (PubMed ID: 3877520)
1. The immunobiology of basal cell carcinoma: an in situ monoclonal antibody study.
Synkowski DR; Schuster P; Orlando JC
Br J Dermatol; 1985 Oct; 113(4):441-6. PubMed ID: 3877520
[TBL] [Abstract][Full Text] [Related]
2. Lymphocytic response to basal-cell carcinoma: in situ identification of functional subsets using monoclonal antibodies.
Eaglstein NF; Hernandez AD; Allen JE
J Dermatol Surg Oncol; 1982 Nov; 8(11):943-7. PubMed ID: 6217236
[No Abstract] [Full Text] [Related]
3. Identification of mononuclear cells infiltrating basal cell carcinomas.
Claudy AL; Viac J; Schmitt D; Alario A; Thivolet J
Acta Derm Venereol; 1976; 56(5):361-5. PubMed ID: 78620
[TBL] [Abstract][Full Text] [Related]
4. [Lymphocyte subpopulations in patients with skin basalioma of the trunk].
Röcken M; Link C; Weber T; Nerl C
Z Hautkr; 1989 Mar; 64(3):212-7. PubMed ID: 2566213
[TBL] [Abstract][Full Text] [Related]
5. [Immunophenotyping and morphometry of inflammatory infiltrates in variants of basalioma].
Ernst TM; Müller-Mai C
Z Hautkr; 1987 Aug; 62(15):1134, 1137-40, 1143-4. PubMed ID: 3314210
[TBL] [Abstract][Full Text] [Related]
6. Skin tumors and reactive cellular infiltrate: further studies.
Claudatus JC; d'Ovidio R; Lospalluti M; Meneghini CL
Acta Derm Venereol; 1986; 66(1):29-34. PubMed ID: 2424211
[TBL] [Abstract][Full Text] [Related]
7. Immune-associated cells in basal cell carcinomas of skin.
Deng JS; Brod BA; Saito R; Tharp MD
J Cutan Pathol; 1996 Apr; 23(2):140-6. PubMed ID: 8721448
[TBL] [Abstract][Full Text] [Related]
8. Expression of activation antigens by T cells infiltrating basal cell carcinomas.
Guillén FJ; Day CL; Murphy GF
J Invest Dermatol; 1985 Sep; 85(3):203-6. PubMed ID: 3875662
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immunity in patients with basal and squamous cell skin cancer.
Weimar VM; Ceilley RI; Goeken JA
J Am Acad Dermatol; 1980 Feb; 2(2):143-7. PubMed ID: 6965945
[TBL] [Abstract][Full Text] [Related]
10. In situ identification of mononuclear cells infiltrating cutaneous carcinoma: an immuno-histochemical study.
De Panfilis G; Colli V; Manfredi G; Misk I; Rima S; Zampetti M; Allegra F
Acta Derm Venereol; 1979; 59(3):219-22. PubMed ID: 87078
[TBL] [Abstract][Full Text] [Related]
11. Regression in basal cell carcinoma: an immunohistochemical analysis.
Hunt MJ; Halliday GM; Weedon D; Cooke BE; Barnetson RS
Br J Dermatol; 1994 Jan; 130(1):1-8. PubMed ID: 7905746
[TBL] [Abstract][Full Text] [Related]
12. Local immune response in basal cell carcinoma: characterization by transmission electron microscopy and monoclonal anti-T6 antibody.
Murphy GF; Krusinski PA; Myzak LA; Ershler WB
J Am Acad Dermatol; 1983 Apr; 8(4):477-85. PubMed ID: 6602155
[TBL] [Abstract][Full Text] [Related]
13. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours.
Viac J; Bustamante R; Thivolet J
Br J Dermatol; 1977 Jul; 97(1):1-10. PubMed ID: 329852
[TBL] [Abstract][Full Text] [Related]
16. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
Buechner SA
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
[TBL] [Abstract][Full Text] [Related]
17. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
[TBL] [Abstract][Full Text] [Related]
18. The dermal cellular infiltrate and cell-mediated immunity in skin carcinomas.
Avgerinou G; Nicolis G; Vareltzidis A; Stratigos J
Dermatologica; 1985; 171(4):238-42. PubMed ID: 4076497
[TBL] [Abstract][Full Text] [Related]
19. Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.
Bertouch JV; Roberts-Thomson PJ; Bradley J
Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1171-2. PubMed ID: 6220755
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.
Faure M; Thivolet J
J Clin Immunol; 1982 Jul; 2(3 Suppl):103S-110S. PubMed ID: 6215423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
